Edward Li

1.0k total citations
41 papers, 672 citations indexed

About

Edward Li is a scholar working on Oncology, Economics and Econometrics and Immunology. According to data from OpenAlex, Edward Li has authored 41 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Economics and Econometrics and 9 papers in Immunology. Recurrent topics in Edward Li's work include Neutropenia and Cancer Infections (9 papers), Biosimilars and Bioanalytical Methods (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Edward Li is often cited by papers focused on Neutropenia and Cancer Infections (9 papers), Biosimilars and Bioanalytical Methods (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Edward Li collaborates with scholars based in United States, Canada and Japan. Edward Li's co-authors include James M. Hoffman, Shusil K. Pandit, Jing Li, Alain de Bruin, Chang‐Gong Liu, Whitney M. Cleghorn, Hui-Zi Chen, Hasan Siddiqui, Michael Weinstein and Gustavo Leone and has published in prestigious journals such as The Journal of Cell Biology, Developmental Cell and Journal of the American Academy of Dermatology.

In The Last Decade

Edward Li

37 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Li United States 13 291 177 108 101 60 41 672
Ciska Verbaanderd Belgium 9 216 0.7× 100 0.6× 36 0.3× 61 0.6× 40 0.7× 12 526
Nicolas Frey Switzerland 19 237 0.8× 89 0.5× 103 1.0× 33 0.3× 46 0.8× 48 932
David L. DeRemer United States 17 310 1.1× 295 1.7× 139 1.3× 25 0.2× 52 0.9× 64 1.1k
Silvio Ken Garattini Italy 13 278 1.0× 279 1.6× 77 0.7× 49 0.5× 16 0.3× 42 733
Linda S. Wood United States 20 392 1.3× 283 1.6× 57 0.5× 29 0.3× 99 1.6× 45 1.2k
Jeffrey Skolnik United States 17 554 1.9× 518 2.9× 95 0.9× 46 0.5× 146 2.4× 32 1.2k
Martha MacLean Canada 12 392 1.3× 267 1.5× 63 0.6× 28 0.3× 23 0.4× 13 670
Anshu Marathe United States 11 183 0.6× 203 1.1× 72 0.7× 41 0.4× 50 0.8× 22 559
Niya Xiong United States 12 305 1.0× 256 1.4× 68 0.6× 15 0.1× 35 0.6× 37 693
Ellen V. Sigal United States 10 81 0.3× 103 0.6× 43 0.4× 137 1.4× 26 0.4× 23 405

Countries citing papers authored by Edward Li

Since Specialization
Citations

This map shows the geographic impact of Edward Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Li more than expected).

Fields of papers citing papers by Edward Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Li. The network helps show where Edward Li may publish in the future.

Co-authorship network of co-authors of Edward Li

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Li. A scholar is included among the top collaborators of Edward Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Li. Edward Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trivedi, Harsh, Tushar Khot, Mareike Hartmann, et al.. (2024). AppWorld: A Controllable World of Apps and People for Benchmarking Interactive Coding Agents. 16022–16076.
2.
Carroll, Shannon H., Kenta Kawasaki, Amélie M. Julé, et al.. (2024). Genetic requirement of dact1/2 to regulate noncanonical Wnt signaling and calpain 8 during embryonic convergent extension and craniofacial morphogenesis. eLife. 13. 3 indexed citations
3.
Li, Edward, et al.. (2024). Budget Impact Analysis of Biosimilar Natalizumab in the US. The American Journal of Managed Care. 30(7). e191–e197. 2 indexed citations
4.
Li, Edward, et al.. (2024). Student reflections as a catalyst for teacher reflective practice in teaching English for Academic Purposes (EAP). Reflective Practice. 25(2). 194–209. 1 indexed citations
5.
Li, Edward, et al.. (2023). 43336 Low-dose oral minoxidil for alopecia: a single-center retrospective review. Journal of the American Academy of Dermatology. 89(3). AB62–AB62. 1 indexed citations
6.
Li, Edward, et al.. (2023). Risk of chemotherapy-induced febrile neutropenia in intermediate-risk regimens: Clinical and economic outcomes of granulocyte colony-stimulating factor prophylaxis. Journal of Managed Care & Specialty Pharmacy. 29(2). 128–138. 2 indexed citations
7.
Boull, Christina, Edward Li, Nathan Rubin, et al.. (2020). Cutaneous reactions in children treated with MEK inhibitors, BRAF inhibitors, or combination therapy: A multicenter study. Journal of the American Academy of Dermatology. 84(6). 1554–1561. 27 indexed citations
8.
Hanke, Steve H. & Edward Li. (2019). The Strange and Futile World of Trade Wars. Journal of applied corporate finance. 31(4). 59–67.
9.
Shah, Parth D., et al.. (2018). Characterizing the demographics of chronic pain patients in the state of Maine using the Maine all payer claims database. BMC Public Health. 18(1). 810–810. 31 indexed citations
10.
Li, Edward, Jennifer Liu, & Monica Ramchandani. (2017). A Framework for Integrating Biosimilars Into the Didactic Core Requirements of a Doctor of Pharmacy Curriculum. American Journal of Pharmaceutical Education. 81(3). 57–57. 6 indexed citations
11.
Li, Edward, Farzad Khalvati, Mohammad Javad Shafiee, Masoom A. Haider, & Alexander Wong. (2016). Sparse reconstruction of compressive sensing MRI using cross-domain stochastically fully connected conditional random fields. BMC Medical Imaging. 16(1). 51–51. 1 indexed citations
12.
Li, Edward, et al.. (2015). Rest mutant zebrafish swim erratically and display atypical spatial preferences. Behavioural Brain Research. 284. 238–248. 6 indexed citations
13.
Grampp, Gustavo, et al.. (2015). Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars. Expert Opinion on Drug Safety. 14(3). 349–360. 12 indexed citations
14.
Li, Edward, et al.. (2015). Development of biosimilars in an era of oncologic drug shortages. Drug Design Development and Therapy. 9. 3247–3247. 34 indexed citations
15.
Soh, Boon-Seng, Kristina Buac, Huansheng Xu, et al.. (2014). N-cadherin prevents the premature differentiation of anterior heart field progenitors in the pharyngeal mesodermal microenvironment. Cell Research. 24(12). 1420–1432. 32 indexed citations
16.
Li, Edward & James M. Hoffman. (2013). Implications of the FDA Draft Guidance on Biosimilars for Clinicians: What We Know and Don't Know. Journal of the National Comprehensive Cancer Network. 11(4). 368–372. 5 indexed citations
17.
Li, Edward, et al.. (2013). Hospital Management of Outpatient Oncology Treatment Decisions: A Survey to Identify Strategies and Concerns. Journal of Oncology Practice. 9(5). e248–e254. 6 indexed citations
18.
Hoffman, James M., Edward Li, Fred Doloresco, et al.. (2012). Projecting future drug expenditures—2012. American Journal of Health-System Pharmacy. 69(5). 405–421. 60 indexed citations
19.
Li, Jing, Cong Ran, Edward Li, et al.. (2008). Synergistic Function of E2F7 and E2F8 Is Essential for Cell Survival and Embryonic Development. Developmental Cell. 14(1). 62–75. 170 indexed citations
20.
Li, Edward. (2005). Oncology pharmacy practice residency programs. American Journal of Health-System Pharmacy. 62(19). 1980–1981. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026